Home/Pipeline/GAD Treatment

GAD Treatment

Generalized Anxiety Disorder

Approved (Japan)Active

Key Facts

Indication
Generalized Anxiety Disorder
Phase
Approved (Japan)
Status
Active
Company

About Viatris (2)

Viatris is a global healthcare leader with a mission to empower people worldwide to live healthier at every stage of life by ensuring reliable access to essential medicines. Its strategy leverages unparalleled scale, geographic reach, and operational excellence across development, manufacturing, and commercialization. The company is executing a strategic transformation, divesting non-core assets to strengthen its financial profile while investing in key growth areas like complex generics, biosimilars, and novel products to drive sustainable revenue and earnings growth through 2030.

View full company profile